Please Wait

Applying Filters...

Caraway
CEP/COS
Table View

Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Caraway

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 CEP/COS, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 1 Europe, 1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 1 SPI Pharma, 3 Kirsch Pharma, 5 Actylis, 2 BASF, 1 CD Formulation, 2 Gangwal Chemicals, 1 Ideal Cures, 3 Kerry, 1 Pluviaendo, 1 Roquette, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

9 Parenteral, 5 Chewable & Orodispersible Aids, 4 Fillers, Diluents & Binders, 4 Taste Masking, 3 Topical, 3 Coating Systems & Additives, 2 Granulation, 2 Controlled & Modified Release, 2 Direct Compression, 2 Thickeners and Stabilizers, 2 Disintegrants & Superdisintegrants, 1 Film Formers & Plasticizers, 1 Co-Processed Excipients, 1 API Stability Enhancers